We offer new opportunities to better understand genetic CNS conditions and advance precision therapeutics.
Q-State Biosciences has world-class capabilities for probing CNS disorders of genetic origin. These capabilities combine advanced genetic sequencing techniques in our CLIA-certified laboratory with proprietary data analytics to provide highly accurate genetic diagnoses. With our expertise in stem cell technology, we can also generate cellular models that capture disease-relevant biology and serve as platforms for functional analysis and targeted drug discovery. This work often leverages our proprietary OptopatchTM technology, which provides comprehensive optical read-outs of electrophysiological activity for robust evaluation of current or prospective therapies.
Precision Medicine Services
We leverage our technologies and capabilities to offer precision medicine services for individuals with rare, genetic neurological conditions. These services range from genetic diagnosis to patient-specific disease modeling and therapeutic evaluation, with the goal of providing individuals a path forward in their search for information about their unique condition. We regularly collaborate with foundations and advocacy groups, including the Rett Syndrome Research Trust, to provide our services for members of their organization.
We also engage in both internal and partnered drug discovery efforts to identify therapies that could benefit broader patient populations. Our significant collaborations with both pharmaceutical partners, including UCB and Vertex, involve using OptopatchTM technology to discover and advance precision therapies for a variety of disorders.
If you are interested in collaborating with us, please reach out to us at firstname.lastname@example.org. We are always seeking new partners and would be happy to speak to you about opportunities to work together and achieve our mutual goals.